Department of General Surgery, Jiyang District People's Hospital, Jinan, Shandong Province, China.
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7598-7611. doi: 10.26355/eurrev_202007_22258.
Long-chain non-coding RNA (LncRNA) is abnormally expressed in various malignant tumors. In recent years, it has been found that the expression of LncRNA SNHG6 is upregulated in gallbladder carcinoma tissues, which participated in the occurrence and development of gallbladder carcinoma. However, the clinical value of SNHG6 in gallbladder cancer serum is not clear, and there are few studies regulating the biological function of gallbladder carcinoma cells. This study aimed to investigate LncRNA SNHG6 and miR-26b-5p in gallbladder carcinoma and its related mechanisms.
From February 2017 to February 2019, altogether 68 cases of gallbladder cancer patients admitted to the Yantai Yeda Hospital were collected as a study group, 70 healthy people as a control group. Gallbladder cancer cells and human colorectal mucosa cells were purchased. Sh-SNHG6, si-SNHG6, NC, miR-26b-5p-inhibitor, and miR-26b-5p-mimics were transfected into GBC-SD and NOZ cells. For the detection of SNHG6 and miR-26b-5p in samples we used qRT-PCR, WB was applied for the decreased protein expression of Gli1, Gli2, Shh, Smo, N-cadherin, vimentin, Snail, E-Cadherin, and Gli3 in cells. MTT assay was applied for the detection of cell proliferation, transwell assay for cell invasion, and flow cytometry assay for apoptosis.
SNHG6 was highly expressed in gallbladder carcinoma, miR-26b-5p was downregulated, and the area under curve (AUC) of LncRNA SNHG6 and miR-26b-5p was more than 0.8. LncRNA SNHG6 and miR-26b-5p were related to age, sex, tumor invasion, differentiation degree, tumor location, and tumor-node-metastasis (TNM) staging of gallbladder cancer patients. Silencing of SNHG6 and upregulation of miR-26b-5p could promote cell apoptosis, inhibit cell growth, and epithelial-mesenchymal transition (ETM). Silencing of SNHG6 and upregulation of miR-26b-5p could inhibit Gli1, Gli2, Shh, Smo, N-cadherin, vimentin and Snail proteins, and promote upregulation of Gli3 and E-Cadherin expression. Dual-Luciferase report confirmed that SNHG6 and miR-26b-5p have targeted relationship. Rescue experiments showed that after co-transfecting sh-SNHG6+miR-26b-5p-mimics, and si-SNHG6+miR-26b-5p-inhibitor into GBC-SD and NOZ, the proliferation, invasion and apoptosis of cells were not different from those of miR-NC group without transfection sequence.
Inhibition of LncRNA SNHG6 expression can upregulate miR-26b-5p mediated Hedgehog signaling pathway, affect epithelial-mesenchymal transition, proliferation and invasion of cells, so LncRNA SNHG6is hoped to be a latent therapeutic target for gallbladder carcinoma.
长链非编码 RNA(LncRNA)在各种恶性肿瘤中异常表达。近年来,研究发现 LncRNA SNHG6 在胆囊癌组织中表达上调,参与了胆囊癌的发生发展。然而,SNHG6 在胆囊癌血清中的临床价值尚不清楚,调控胆囊癌细胞生物学功能的研究较少。本研究旨在探讨 LncRNA SNHG6 和 miR-26b-5p 在胆囊癌中的表达及其相关机制。
2017 年 2 月至 2019 年 2 月,收集烟台业达医院收治的 68 例胆囊癌患者作为研究组,70 例健康人作为对照组。购买胆囊癌细胞和人结直肠黏膜细胞。将 Sh-SNHG6、si-SNHG6、NC、miR-26b-5p 抑制剂和 miR-26b-5p 模拟物转染至 GBC-SD 和 NOZ 细胞。使用 qRT-PCR 检测样本中的 SNHG6 和 miR-26b-5p,使用 WB 检测 Gli1、Gli2、Shh、Smo、N-钙黏蛋白、波形蛋白、Snail、E-钙黏蛋白和 Gli3 蛋白在细胞中的表达降低。MTT 法检测细胞增殖,Transwell 法检测细胞侵袭,流式细胞术检测细胞凋亡。
SNHG6 在胆囊癌中高表达,miR-26b-5p 下调,LncRNA SNHG6 和 miR-26b-5p 的曲线下面积(AUC)均大于 0.8。LncRNA SNHG6 和 miR-26b-5p 与胆囊癌患者的年龄、性别、肿瘤侵袭、分化程度、肿瘤部位和肿瘤-淋巴结-转移(TNM)分期有关。沉默 SNHG6 和上调 miR-26b-5p 可促进细胞凋亡,抑制细胞生长和上皮-间充质转化(EMT)。沉默 SNHG6 和上调 miR-26b-5p 可抑制 Gli1、Gli2、Shh、Smo、N-钙黏蛋白、波形蛋白和 Snail 蛋白表达,促进 Gli3 和 E-钙黏蛋白表达上调。双荧光素酶报告证实 SNHG6 和 miR-26b-5p 具有靶向关系。挽救实验表明,当同时将 sh-SNHG6+miR-26b-5p-mimics 和 si-SNHG6+miR-26b-5p-inhibitor 转染至 GBC-SD 和 NOZ 细胞后,与未转染序列的 miR-NC 组相比,细胞的增殖、侵袭和凋亡无差异。
抑制 LncRNA SNHG6 表达可上调 Hedgehog 信号通路介导的 miR-26b-5p,影响细胞的上皮-间充质转化、增殖和侵袭,因此 LncRNA SNHG6 有望成为胆囊癌的潜在治疗靶点。